COMERICA INC (CMA)

US2003401070 - Common Stock

61.16  +1.15 (+1.92%)

After market: 61.16 0 (0%)

Fundamental Rating

3

Taking everything into account, CMA scores 3 out of 10 in our fundamental rating. CMA was compared to 406 industry peers in the Banks industry. CMA has a bad profitability rating. Also its financial health evaluation is rather negative. CMA has a valuation in line with the averages, but on the other hand it scores bad on growth. CMA also has an excellent dividend rating.



3

1. Profitability

1.1 Basic Checks

CMA had positive earnings in the past year.
In the past year CMA had a positive cash flow from operations.
Each year in the past 5 years CMA has been profitable.
Each year in the past 5 years CMA had a positive operating cash flow.

1.2 Ratios

The Return On Assets of CMA (0.67%) is comparable to the rest of the industry.
CMA's Return On Equity of 7.26% is in line compared to the rest of the industry. CMA outperforms 43.32% of its industry peers.
Industry RankSector Rank
ROA 0.67%
ROE 7.26%
ROIC N/A
ROA(3y)1.17%
ROA(5y)1.14%
ROE(3y)16.47%
ROE(5y)14.34%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

CMA has a worse Profit Margin (16.71%) than 69.80% of its industry peers.
CMA's Profit Margin has declined in the last couple of years.
CMA does not have Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) 16.71%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y12.83%
PM growth 5Y-8.4%
GM growth 3YN/A
GM growth 5YN/A

3

2. Health

2.1 Basic Checks

CMA does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, CMA has more shares outstanding
The number of shares outstanding for CMA has been reduced compared to 5 years ago.
CMA has a better debt/assets ratio than last year.

2.2 Solvency

CMA has a debt to FCF ratio of 1.46. This is a very positive value and a sign of high solvency as it would only need 1.46 years to pay back of all of its debts.
CMA's Debt to FCF ratio of 1.46 is fine compared to the rest of the industry. CMA outperforms 68.56% of its industry peers.
CMA has a Debt/Equity ratio of 0.38. This is a healthy value indicating a solid balance between debt and equity.
CMA has a Debt to Equity ratio of 0.38. This is in the lower half of the industry: CMA underperforms 71.04% of its industry peers.
Even though the debt/equity ratio score it not favorable for CMA, it has very limited outstanding debt, so we won't put too much weight on the DE evaluation.
Industry RankSector Rank
Debt/Equity 0.38
Debt/FCF 1.46
Altman-Z N/A
ROIC/WACCN/A
WACC11.92%

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A

1

3. Growth

3.1 Past

The earnings per share for CMA have decreased strongly by -36.85% in the last year.
CMA shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 1.13% yearly.
The Revenue for CMA has decreased by -16.42% in the past year. This is quite bad
CMA shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 1.54% yearly.
EPS 1Y (TTM)-36.85%
EPS 3Y33.04%
EPS 5Y1.13%
EPS Q2Q%-27.72%
Revenue 1Y (TTM)-16.42%
Revenue growth 3Y7.25%
Revenue growth 5Y1.54%
Sales Q2Q%-9.49%

3.2 Future

CMA is expected to show a decrease in Earnings Per Share. In the coming years, the EPS will decrease by -6.46% yearly.
CMA is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -1.06% yearly.
EPS Next Y-33.21%
EPS Next 2Y-15.18%
EPS Next 3Y-6.76%
EPS Next 5Y-6.46%
Revenue Next Year-10.1%
Revenue Next 2Y-2.91%
Revenue Next 3Y-0.86%
Revenue Next 5Y-1.06%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.

5

4. Valuation

4.1 Price/Earnings Ratio

CMA is valuated reasonably with a Price/Earnings ratio of 10.98.
Compared to the rest of the industry, the Price/Earnings ratio of CMA indicates a somewhat cheap valuation: CMA is cheaper than 75.99% of the companies listed in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 27.73, CMA is valued rather cheaply.
Based on the Price/Forward Earnings ratio of 11.04, the valuation of CMA can be described as reasonable.
Based on the Price/Forward Earnings ratio, CMA is valued a bit cheaper than 60.89% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of CMA to the average of the S&P500 Index (22.83), we can say CMA is valued rather cheaply.
Industry RankSector Rank
PE 10.98
Fwd PE 11.04

4.2 Price Multiples

93.07% of the companies in the same industry are more expensive than CMA, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 4.24
EV/EBITDA N/A

4.3 Compensation for Growth

CMA's earnings are expected to decrease with -6.76% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)9.73
EPS Next 2Y-15.18%
EPS Next 3Y-6.76%

7

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 4.73%, CMA is a good candidate for dividend investing.
CMA's Dividend Yield is rather good when compared to the industry average which is at 3.15. CMA pays more dividend than 86.88% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 2.34, CMA pays a better dividend.
Industry RankSector Rank
Dividend Yield 4.73%

5.2 History

The dividend of CMA is nicely growing with an annual growth rate of 13.67%!
CMA has been paying a dividend for at least 10 years, so it has a reliable track record.
CMA has not decreased its dividend in the past 5 years, so it has a somewhat stable track record.
Dividend Growth(5Y)13.67%
Div Incr Years1
Div Non Decr Years7

5.3 Sustainability

CMA pays out 74.39% of its income as dividend. This is not a sustainable payout ratio.
The Dividend Rate of CMA has been growing, while earnings will be declining. This means the dividend growth is most likely not sustainable.
DP74.39%
EPS Next 2Y-15.18%
EPS Next 3Y-6.76%

COMERICA INC

NYSE:CMA (12/20/2024, 8:04:00 PM)

After market: 61.16 0 (0%)

61.16

+1.15 (+1.92%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupBanks
GICS IndustryBanks
Earnings (Last)10-18 2024-10-18/bmo
Earnings (Next)01-22 2025-01-22/amc
Inst Owners82.79%
Inst Owner Change3.99%
Ins Owners0.8%
Ins Owner Change0.34%
Market Cap8.04B
Analysts70
Price Target70.43 (15.16%)
Short Float %3.87%
Short Ratio2.58
Dividend
Industry RankSector Rank
Dividend Yield 4.73%
Dividend Growth(5Y)13.67%
DP74.39%
Div Incr Years1
Div Non Decr Years7
Ex-Date12-13 2024-12-13 (0.71)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)18.38%
Min EPS beat(2)13.07%
Max EPS beat(2)23.68%
EPS beat(4)4
Avg EPS beat(4)14.11%
Min EPS beat(4)5.87%
Max EPS beat(4)23.68%
EPS beat(8)8
Avg EPS beat(8)9.37%
EPS beat(12)11
Avg EPS beat(12)7.01%
EPS beat(16)15
Avg EPS beat(16)15.08%
Revenue beat(2)1
Avg Revenue beat(2)-0.39%
Min Revenue beat(2)-1.06%
Max Revenue beat(2)0.29%
Revenue beat(4)1
Avg Revenue beat(4)-3.07%
Min Revenue beat(4)-7.76%
Max Revenue beat(4)0.29%
Revenue beat(8)5
Avg Revenue beat(8)-1.06%
Revenue beat(12)8
Avg Revenue beat(12)-0.74%
Revenue beat(16)11
Avg Revenue beat(16)-0.2%
PT rev (1m)6.98%
PT rev (3m)25.13%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-11.69%
EPS NY rev (1m)0.21%
EPS NY rev (3m)6.14%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-3.78%
Revenue NY rev (1m)0.09%
Revenue NY rev (3m)0.21%
Valuation
Industry RankSector Rank
PE 10.98
Fwd PE 11.04
P/S 2.51
P/FCF 4.24
P/OCF 3.87
P/B 1.09
P/tB 1.09
EV/EBITDA N/A
EPS(TTM)5.57
EY9.11%
EPS(NY)5.54
Fwd EY9.06%
FCF(TTM)14.44
FCFY23.61%
OCF(TTM)15.79
OCFY25.82%
SpS24.34
BVpS56.01
TBVpS56.01
PEG (NY)N/A
PEG (5Y)9.73
Profitability
Industry RankSector Rank
ROA 0.67%
ROE 7.26%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 16.71%
GM N/A
FCFM 59.33%
ROA(3y)1.17%
ROA(5y)1.14%
ROE(3y)16.47%
ROE(5y)14.34%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y12.83%
PM growth 5Y-8.4%
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.04
Health
Industry RankSector Rank
Debt/Equity 0.38
Debt/FCF 1.46
Debt/EBITDA N/A
Cap/Depr 191.4%
Cap/Sales 5.56%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality 354.95%
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score4
WACC11.92%
ROIC/WACCN/A
Cap/Depr(3y)111.9%
Cap/Depr(5y)96.86%
Cap/Sales(3y)2.98%
Cap/Sales(5y)2.84%
Profit Quality(3y)75.87%
Profit Quality(5y)97.55%
High Growth Momentum
Growth
EPS 1Y (TTM)-36.85%
EPS 3Y33.04%
EPS 5Y1.13%
EPS Q2Q%-27.72%
EPS Next Y-33.21%
EPS Next 2Y-15.18%
EPS Next 3Y-6.76%
EPS Next 5Y-6.46%
Revenue 1Y (TTM)-16.42%
Revenue growth 3Y7.25%
Revenue growth 5Y1.54%
Sales Q2Q%-9.49%
Revenue Next Year-10.1%
Revenue Next 2Y-2.91%
Revenue Next 3Y-0.86%
Revenue Next 5Y-1.06%
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y384.44%
FCF growth 3Y8.95%
FCF growth 5Y-6.37%
OCF growth 1Y341.92%
OCF growth 3Y10.47%
OCF growth 5Y-4.99%